| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 534* | 2021 |
| Risk of bleeding with dabigatran in atrial fibrillation I Hernandez, SH Baik, A Piñera, Y Zhang JAMA internal medicine 175 (1), 18-24, 2015 | 347 | 2015 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 234 | 2021 |
| Changes in list prices, net prices, and discounts for branded drugs in the US, 2007-2018 I Hernandez, A San-Juan-Rodriguez, CB Good, WF Gellad Jama 323 (9), 854-862, 2020 | 162 | 2020 |
| Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in Medicare Part D beneficiaries I Hernandez, M He, MM Brooks, Y Zhang JAMA network open 1 (2), e180919-e180919, 2018 | 135 | 2018 |
| Evaluation of frequency of encounters with primary care physicians vs visits to community pharmacies among Medicare beneficiaries LA Berenbrok, N Gabriel, KC Coley, I Hernandez JAMA Network Open 3 (7), e209132-e209132, 2020 | 129 | 2020 |
| Pricing of monoclonal antibody therapies: higher if used for cancer I Hernandez, SW Bott, AS Patel, CG Wolf, AR Hospodar, S Sampathkumar, ... Am J Manag Care 24 (2), 109-112, 2018 | 125 | 2018 |
| Total costs of chimeric antigen receptor T-cell immunotherapy I Hernandez, V Prasad, WF Gellad JAMA oncology 4 (7), 994-996, 2018 | 119 | 2018 |
| Comparison of the effectiveness and safety of apixaban, dabigatran, rivaroxaban, and warfarin in newly diagnosed atrial fibrillation I Hernandez, Y Zhang, S Saba The American journal of cardiology 120 (10), 1813-1819, 2017 | 119 | 2017 |
| Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis LA Berenbrok, S Tang, N Gabriel, J Guo, N Sharareh, N Patel, S Dickson, ... Journal of the American Pharmacists Association 62 (6), 1816-1822. e2, 2022 | 117 | 2022 |
| Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: an umbrella review TV Newman, A San-Juan-Rodriguez, N Parekh, ECS Swart, ... Research in Social and Administrative Pharmacy 16 (9), 1155-1165, 2020 | 104 | 2020 |
| Reproductive cycle of two commercial species of sea cucumber (Echinodermata: Holothuroidea) from Caribbean Panama H Guzmán, C Guevara, I Hernández Marine Biology 142, 271-279, 2003 | 90 | 2003 |
| Coverage, formulary restrictions, and out-of-pocket costs for sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in the Medicare Part D program J Luo, R Feldman, SD Rothenberger, I Hernandez, WF Gellad JAMA Network Open 3 (10), e2020969-e2020969, 2020 | 81 | 2020 |
| Comparing stroke and bleeding with rivaroxaban and dabigatran in atrial fibrillation: analysis of the US Medicare Part D data I Hernandez, Y Zhang American Journal of Cardiovascular Drugs 17, 37-47, 2017 | 81 | 2017 |
| Using predictive analytics and big data to optimize pharmaceutical outcomes I Hernandez, Y Zhang American journal of health-system pharmacy 74 (18), 1494-1500, 2017 | 79 | 2017 |
| Trajectories of oral anticoagulation adherence among Medicare beneficiaries newly diagnosed with atrial fibrillation I Hernandez, M He, N Chen, MM Brooks, S Saba, WF Gellad Journal of the American Heart Association 8 (12), e011427, 2019 | 63 | 2019 |
| Impact of community pharmacist-provided preventive services on clinical, utilization, and economic outcomes: an umbrella review A San-Juan-Rodriguez, TV Newman, I Hernandez, ECS Swart, ... Preventive medicine 115, 145-155, 2018 | 60 | 2018 |
| SARS‐CoV‐2 infection and venous thromboembolism after surgery: an international prospective cohort study COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ... Anaesthesia 77 (1), 28-39, 2022 | 59 | 2022 |
| The contribution of new product entry versus existing product inflation in the rising costs of drugs I Hernandez, CB Good, DM Cutler, WF Gellad, N Parekh, WH Shrank Health Affairs 38 (1), 76-83, 2019 | 56 | 2019 |
| Cost-effectiveness of dapagliflozin for the treatment of heart failure with reduced ejection fraction N Isaza, P Calvachi, I Raber, CL Liu, BK Bellows, I Hernandez, C Shen, ... JAMA Network Open 4 (7), e2114501-e2114501, 2021 | 53 | 2021 |
